Federal contractor · PITTSBURGH, PA

CONSEGNA PHARMA INC

No contract obligations recorded for CONSEGNA PHARMA INC in FY2026. Since FY2020: $1.3M.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
NU7SAKDR52N8
Small business

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 167.4KFY2020
  2. 1.1MFY2022
  3. 0FY2023

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for CONSEGNA PHARMA INC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

CONSEGNA PHARMA INC received $0 in federal assistance in FY2026, on 2 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
2
Since FY2021
$2.9M

Assistance by fiscal year

  1. 0FY2021
  2. 1.7MFY2023
  3. 837.4KFY2024
  4. 377.8KFY2025
  5. 0FY2026

Largest awards

  1. 93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Project grant· Sep 14, 2023 – Dec 13, 2025· R44DA050386
  2. 93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Project grant· Aug 10, 2023 – Feb 11, 2026· R43DA059056

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.